Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Pelthos Therapeutics Inc.

NYSE: PTHS · Life Sciences · 7 alerts · CIK 1919246

Share price
$7.15Close, Nov 16
Market cap
$28.1M
Shares outstanding
3.93MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Pelthos Therapeutics Inc. filings on SEC EDGAR ↗

5:54 PM ET Form 4
Insider Selling

Pelthos Therapeutics Insider Peter Greenleaf Sells $16.9K of Stock

Peter Greenleaf sold 797 shares of Pelthos Therapeutics Inc. at $21.17 a share, worth $16.9K in total on Oct 2, 2026. Shares held after the trade: 23,087 (-3.3%).

Value
$16.9K
Shares
797
Price
$21.17
Holding change
-3.3%
Trade date
Oct 2, 2026
5:54 PM ET Form 4
Insider Selling

Pelthos Therapeutics Insider Ezra M. Friedberg Sells $11.6K of Stock

Ezra M. Friedberg sold 558 shares of Pelthos Therapeutics Inc. at $20.72 a share, worth $11.6K in total on Oct 2, 2026. Shares held after the trade: 80,484 (-0.7%).

Value
$11.6K
Shares
558
Price
$20.72
Holding change
-0.7%
Trade date
Oct 2, 2026
5:54 PM ET Form 4
Insider Selling

Pelthos Therapeutics Insider Matthew Pauls Sells $16.5K of Stock

Matthew Pauls sold 786 shares of Pelthos Therapeutics Inc. at $21.00 a share, worth $16.5K in total on Oct 2, 2026. Shares held after the trade: 13,578 (-5.5%).

Value
$16.5K
Shares
786
Price
$21.00
Holding change
-5.5%
Trade date
Oct 2, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.